Cargando…
Increased Targeting Area in Tumors by Dual-Ligand Modification of Liposomes with RGD and TAT Peptides
Modification with polyethylene glycol (PEGylation) and the use of rigid phospholipids drastically improve the pharmacokinetics of chemotherapeutics and result in more manageable or reduced side-effects. A major drawback is retarded cellular delivery of content, which, along with tumor heterogeneity,...
Autores principales: | Amin, Mohamadreza, Mansourian, Mercedeh, Burgers, Peter C., Amin, Bahareh, Jaafari, Mahmoud Reza, ten Hagen, Timo L. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878433/ https://www.ncbi.nlm.nih.gov/pubmed/35214190 http://dx.doi.org/10.3390/pharmaceutics14020458 |
Ejemplares similares
-
Regulation of in vivo behavior of TAT-modified liposome by associated protein corona and avidity to tumor cells
por: Amin, Mohamadreza, et al.
Publicado: (2018) -
Enhanced Specificity and Drug Delivery in Tumors by cRGD - Anchoring Thermosensitive Liposomes
por: Dicheva, Bilyana M., et al.
Publicado: (2015) -
Preparation and evaluation of RGD and TAT co-modified docetaxel-loaded liposome
por: Zhu, Ren, et al.
Publicado: (2017) -
Preparation and characterization of different liposomal formulations containing P5 HER2/neu-derived peptide and evaluation of their immunological responses and antitumor effects
por: Shariat, Sheida, et al.
Publicado: (2015) -
Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma
por: Nik, Maryam Ebrahimi, et al.
Publicado: (2019)